LRP4 and amyotrophic lateral sclerosis: Interestingly, LRP4 antibodies have also been reported in 10–23% of amyotrophic lateral sclerosis (ALS) patients (50, 51) and in 3.6% patients with other neurological diseases but not in healthy controls (47).